Valuation: Clover Corporation Limited

Market Cap 14Cr 10Cr 8.81Cr 8.18Cr 7.53Cr 14Cr 969.79Cr 98Cr 38Cr 473.02Cr 38Cr 37Cr 1.64TCr P/E 2026 *
14.8x
P/E 2027 * 10.7x
Enterprise Value 14Cr 9.85Cr 8.67Cr 8.05Cr 7.4Cr 14Cr 954.27Cr 96Cr 38Cr 465.45Cr 37Cr 36Cr 1.61TCr EV / Sales 2026 *
1.5x
EV / Sales 2027 * 1.18x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day-2.81%
1 week+2.37%
Current month+2.37%
1 month-1.70%
3 months-13.50%
6 months+12.34%
Current year+9.49%
1 week 0.83
Extreme 0.83
0.89
1 month 0.7
Extreme 0.7
0.9
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.52
1.16
3 years 0.34
Extreme 0.337
1.17
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

2,55,199 0.1528%
18/11/25 Buy

Chief Executive Officer

5,29,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.81%+2.37%+64.76%-26.07% 10Cr
+3.82%+9.52%+41.79%+95.93% 1.39TCr
-2.84%-8.07%-26.50%+249.15% 817.22Cr
-0.99%+0.60%-14.71%-52.06% 250.58Cr
-2.86%+3.29%-77.40%-64.78% 148.6Cr
-2.81%-24.96% - - 124.05Cr
+0.59%-8.86%-30.17%-27.00% 122.49Cr
-3.65%-4.93%+8.59%-24.81% 126.37Cr
-0.38%-2.47%+18.73%+43.00% 120.8Cr
-3.18%-15.41%-68.69%-72.97% 93Cr
Average -1.53%-1.81%-9.29%+13.38% 320.05Cr
Weighted average by Cap. +0.37%+2.92%+4.89%+99.36%

Financials

2026 *2027 *
Net sales 9.4Cr 6.55Cr 5.76Cr 5.35Cr 4.92Cr 9.23Cr 634.59Cr 64Cr 25Cr 309.52Cr 25Cr 24Cr 1.07TCr 12Cr 8.09Cr 7.12Cr 6.61Cr 6.08Cr 11Cr 783.78Cr 79Cr 31Cr 382.29Cr 30Cr 30Cr 1.33TCr
Net income 98L 68.32L 60.08L 55.82L 51.34L 96.27L 66Cr 6.67Cr 2.6Cr 32Cr 2.56Cr 2.51Cr 111.95Cr 1.35Cr 94.11L 82.77L 76.89L 70.72L 1.33Cr 91Cr 9.19Cr 3.59Cr 44Cr 3.53Cr 3.46Cr 154.22Cr
Net Debt -23L -16.03L -14.1L -13.1L -12.05L -22.59L -16Cr -1.57Cr -61.1L -7.57Cr -60.19L -58.89L -26Cr -72L -50.19L -44.14L -41.01L -37.72L -70.73L -49Cr -4.9Cr -1.91Cr -24Cr -1.88Cr -1.84Cr -82Cr
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
23/26/23 A$0.8650 -2.81% 1,63,339
22/26/22 A$0.8900 +2.30% 859
21/26/21 A$0.8700 +1.16% 13,224
20/26/20 A$0.8600 +0.58% 6,043
17/26/17 A$0.8550 +0.59% 17,257
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8650AUD
Average target price
1.280AUD
Spread / Average Target
+47.98%

Annual profits - Rate of surprise